Beijing Science Sun Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 41.01%

Beijing Science Sun Pharmaceutical Co Ltd (300485) has an Asset Resilience Ratio of 41.01% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Beijing Science Sun Pharmaceutical Co Lt to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.38 Billion

≈ $201.81 Million USD Cash + Short-term Investments

Total Assets

CN¥3.36 Billion

≈ $492.03 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Beijing Science Sun Pharmaceutical Co Lt assets under control.

Liquid Assets Composition Over Time

This chart breaks down Beijing Science Sun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Beijing Science Sun Pharmaceutical Co Lt's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.38 Billion	41.01%
Total Liquid Assets	CN¥1.38 Billion	41.01%

Asset Resilience Insights

Very High Liquidity: Beijing Science Sun Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 41.01% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Beijing Science Sun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Science Sun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Beijing Science Sun Pharmaceutical Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Beijing Science Sun Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	41.30%	CN¥1.47 Billion ≈ $215.68 Million	CN¥3.57 Billion ≈ $522.17 Million	-0.82pp
2024-12-31	42.13%	CN¥1.50 Billion ≈ $218.96 Million	CN¥3.55 Billion ≈ $519.75 Million	+13.05pp
2023-12-31	29.08%	CN¥1.05 Billion ≈ $154.15 Million	CN¥3.62 Billion ≈ $530.04 Million	+3.99pp
2022-12-31	25.09%	CN¥895.39 Million ≈ $131.02 Million	CN¥3.57 Billion ≈ $522.27 Million	-8.27pp
2021-12-31	33.35%	CN¥1.13 Billion ≈ $166.03 Million	CN¥3.40 Billion ≈ $497.77 Million	+16.38pp
2020-12-31	16.97%	CN¥507.69 Million ≈ $74.29 Million	CN¥2.99 Billion ≈ $437.69 Million	-0.47pp
2019-12-31	17.44%	CN¥489.34 Million ≈ $71.61 Million	CN¥2.81 Billion ≈ $410.53 Million	+17.54pp
2018-12-31	-0.10%	CN¥-2.66 Million ≈ $-389.17K	CN¥2.76 Billion ≈ $403.96 Million	-22.88pp
2016-12-31	22.78%	CN¥505.00 Million ≈ $73.90 Million	CN¥2.22 Billion ≈ $324.36 Million	-6.78pp
2015-12-31	29.57%	CN¥575.00 Million ≈ $84.14 Million	CN¥1.94 Billion ≈ $284.59 Million	--

pp = percentage points

About Beijing Science Sun Pharmaceutical Co Ltd

SHE:300485 China Drug Manufacturers - Specialty & Generic

Market Cap

$592.76 Million

CN¥4.05 Billion CNY

Market Cap Rank

#11458 Global

#3241 in China

Share Price

CN¥8.41

Change (1 day)

+1.82%

52-Week Range

CN¥8.13 - CN¥13.35

All Time High

CN¥40.48